Medical Care |

Medical Care

##SEVER##

/a/adamspest.com.au1.html

 

Microsoft word - perigen defence residual insecticide.doc

MATERIAL SAFETY DATA SHEET
Perigen® Defence Residual Insecticide

Date of Issue: January 5th, 2004
1. IDENTIFICATION OF THE SUBSTANCE / MIXTURE AND SUPPLIER
Product name:
Perigen® Defence Residual Insecticide
Other names:
Product code:
Recommended
A liquid insecticide concentrate for use in general purpose pest control and fabric and bed-net impregnation Supplier:
Bayer Environmental Science – A Business Group of Bayer CropScience Pty Ltd ABN 87 000 226 022 Address:
391 - 393 Tooronga Road, East Hawthorn Victoria 3123, Australia Telephone:
Facsimile:
Website:
Contact:
Technical Manager (03) 9248 6888 Emergency
Telephone
1800 033 111 – Orica SH&E Shared Services 2. HAZARDS IDENTIFICATION

HAZARDOUS SUBSTANCE - DANGEROUS GOOD
Will irritate eyes and skin. Not flammable. Hazardous according to criteria of Worksafe Australia. designation:
Risk phrases:

R65 – Harmful: May cause lung damage if swallowed Safety phrases:
Not "dangerous goods" for transport by road or rail according to the Australian Code for the Transport of Dangerous Goods by Road and Rail. Schedule 6 (Standard for the Uniform Scheduling of Drugs and Poisons)
3. COMPOSITION / INFORMATION ON INGREDIENTS

Ingredients: CAS
Concentration (g/L):
Permethrin 25:75 Hydrocarbon solvent Other ingredients MATERIAL SAFETY DATA SHEET
Perigen® Defence Residual Insecticide

Date of Issue: January 5th, 2004
4. FIRST AID MEASURES

If poisoning occurs, immediately contact a doctor or Poisons Information Centre
(telephone 13 11 26), and follow the advice given. Show this Material Safety Data Sheet
to a doctor.


Inhalation:

Remove person to fresh air. Keep at rest. Seek medical advice if exposure has been more than trivial. Administer artificial respiration if breathing has stopped. Skin contact:
Remove all contaminated clothing and shoes. Wash off skin immediately with soap and plenty of water. Seek medical advice if irritation persists. Launder contaminated clothing before re-use. Eye contact:
Immediately rinse eyes thoroughly, including under eyelids, with running water for at least 15 minutes. Seek immediate medical advice. Ingestion:
Seek immediate medical advice. First Aid
Provide an eyewash station in the workplace. Facilities:
Symptoms:
Perigen contains the synthetic pyrethroid permethrin and a hydrocarbon solvent, symptoms are likely to be limited to irritation associated with permethrin and effects of the solvent. Medical attention: There is no specific antidote. Treat symptoms. This product contains a
hydrocarbon solvent. Small amounts of liquid aspirated into the respiratory system during ingestion or from vomiting may cause bronchopneumonia or pulmonary edema.
5. FIRE FIGHTING MEASURES

Extinguishing
Foam, dry chemical or water spray. Do not use a water jet from a fire hose. media:
Hazards from

No data available. combustion
products:
Precautions for

This product is a combustible liquid. Fire fighters should wear full protective fire fighters:
clothing and self-contained breathing apparatus. Do not release contaminated water into the environment. Keep intact containers cool by spraying with water.
6. ACCIDENTAL RELEASE MEASURES

Wear suitable protective clothing and boots. Prevent spill from entering drains, sewers or any body
of water. Contain and absorb with sand, earth or inert absorbent. Scoop or shovel into sealable
containers for disposal in accordance with applicable local, state and federal regulations.
MATERIAL SAFETY DATA SHEET
Perigen® Defence Residual Insecticide

Date of Issue: January 5th, 2004
7. HANDLING AND STORAGE

Handling:
Keep out of reach of children. Avoid contact with skin and eyes and do not inhale spray mist. Use only in a well-ventilated area. Do not apply in the presence of naked flames, hot surfaces or unprotected electrical equipment. Use proper grounding procedures. Storage:
Store product in the closed, original container in a cool, well-ventilated area away from direct sunlight.
8. EXPOSURE CONTROLS / PERSONAL PROTECTION

Exposure
No exposure standard has been assigned by the National Occupational standards:
Health and Safety Commission (Worksafe Australia). The manufacturer of the hydrocarbon solvent recommends an occupational exposure limit of 100 ppm total hydrocarbons. Engineering
Control process conditions to avoid contact. Use local exhaust ventilation. controls:
Keep product away from sources of ignition. Personal
Avoid contact with the eyes. Wear safety goggles. Wear a Protective
face shield if splashing is possible. Equipment:
Wear suitable protective clothing. Protective clothing must be stored separately from private clothing. Avoid contact with the skin. Wear elbow-length PVC or nitrile gloves. Respiratory: Wear an approved respirator to prevent inhalation, if other control measures are inadequate. Other: Do not eat, drink or smoke until after washing. Wash thoroughly after handling. After each day's use wash gloves, goggles and contaminated clothing. 9. PHYSICAL AND CHEMICAL PROPERTIES

Appearance:
Clear yellow limpid liquid Aromatic solvent odour Vapour pressure: No data
Boiling point:
point:
Solubility:

Density:
Flash Point:
0.6 - 7.0% (solvent) (explosive) limits:
Auto-ignition

> 4500C (solvent) temperature:
Percent volatiles:
38
Octanol/water
partition
coefficient:
Formulation:

Emulsifiable concentrate MATERIAL SAFETY DATA SHEET
Perigen® Defence Residual Insecticide

Date of Issue: January 5th, 2004
10. STABILITY AND REACTIVITY

Chemical
stability:
Hazardous
polymerisation:
Conditions to

avoid:
Incompatible

Incompatible with strong oxidising agents materials:
Hazardous

decomposition
products:

11. TOXICOLOGICAL INFORMATION

POTENTIAL HEALTH EFFECTS
Inhalation:
Avoid breathing vapour / spray / fumes. Inhalation of spray may produce respiratory irritation and can result in headaches, dizziness, drowsiness, and possibly nausea. Skin contact:
Mild irritant and drying to the skin. The material should not be allowed to come into contact with the skin. Eye contact:
Irritating. The material should not be allowed to contact the eyes. Ingestion:
Harmful if swallowed. ANIMAL TOXICITY DATA – PRODUCT: No data available for the product. ANIMAL TOXICITY DATA – INDIVIDUAL INGREDIENTS: Acute:

Oral toxicity:
LD50 rat: 1479mg/kg (permethrin 25:75 in corn oil) Dermal toxicity:
LD50 rabbit: >2000mg/kg (permethrin) Inhalation
toxicity:

Skin irritation:

Mild irritant – rabbit (permethrin) Eye irritation:
Mild irritant – rabbit (permethrin) Chronic:

MATERIAL SAFETY DATA SHEET
Perigen® Defence Residual Insecticide

Date of Issue: January 5th, 2004
Permethrin is not mutagenic, teratogenic or carcinogenic. Skin sensitisation tests carried out by
Bayer CropScience indicate that permethrin active ingredient was not an skin sensitiser.
At high doses, the solvent caused reversible damage to the liver and kidney of male rats. These
effects are not relevant to humans at occupational levels of exposure.
12. ECOLOGICAL INFORMATION

Fish toxicity:
Permethrin is toxic to fish Daphnia toxicity:
Data not available Toxicity to algae: Data not available
Bird toxicity:
Data not available Bee toxicity:
Permethrin is toxic to bees NO data available Permethrin degrades rapidly in soil and water. fate, persistence
and degradation:

13. DISPOSAL CONSIDERATIONS

Follow Avcare guidelines. Do not discharge into drains. Do not incinerate. Dispose of waste
material via a licensed waste disposal contractor to a regulated landfill.
14. TRANSPORT INFORMATION

UN number:
Proper shipping
name:
Class and

Not "dangerous goods" for transport by road or rail according to the Subsidiary Risk: Australian Code for the Transport of Dangerous Goods by Road and Rail.
Packing Group:
Hazchem code:

15. REGULATORY INFORMATION

Registered according to the Agricultural and Veterinary Chemicals Act 1988
Australian Pesticides and Veterinary Medicines Authority Approval Number: 57184
MATERIAL SAFETY DATA SHEET
Perigen® Defence Residual Insecticide

Date of Issue: January 5th, 2004
16. OTHER INFORMATION

Trademark
Perigen® is a Registered Trademark of Bayer Preparation
Replaces July 16, 2001 edition. Reason for update: Conversion to 16 heading format. Data sources:
Bayer CropScience Pty Ltd product safety data and published data This MSDS summarises our best knowledge of the health and safety hazard information of the product and how to safely handle and use the product in the workplace. Each user should read this MSDS and consider the information in the context of how the product will be handled and used in the workplace including in conjunction with other products. If clarification or further information is needed to ensure that an appropriate risk assessment can be made, the user should contact this company. Our responsibility for products sold is subject to our standard terms and conditions, a copy of which is sent to our customers and is also available on request.

Source: http://www.adamspest.com.au/Downloads/msds/PERIGEN%20INSECTICIDE%20MSDS.pdf

Early days in drug discovery by crystallography - personal recollections

Acta Crystallographica Section A Early days in drug discovery by crystallography – personal recollections Received 10 December 2012 Accepted 11 December 2012 The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria, Australia. Correspondence e-mail: The influences of Lawrence Bragg and Max Perutz are evident in thecontemporary emphasis on ‘structural enablement' in drug discovery. Onthis occasion of the centenary of Bragg's equation, his role in supporting theearliest structural studies of biological materials at the Cavendish Laboratory isremembered. The 1962 Nobel Prizes for the structures of DNA and proteinsmarked the golden anniversary of the von Laue and Bragg discoveries.

gilead.com

HIGHLIGHTS OF PRESCRIBING INFORMATION • If used in combination with ribavirin, follow the recommendations for These highlights do not include all the information needed to use ribavirin dosing and dosage modifications (2.1) HARVONI® safely and effectively. See full prescribing information • A dosage recommendation cannot be made for patients with severe